Clinical Trials on Thermobalancing Therapy and Dr. Allen’s Devices Show High Efficacy and Are Expanded from Urological Conditions to Back Pain and Coronary Heart Disease
London, UK (PRWEB) December 29, 2014 -- Fine Treatment is pleased to report on a significant acknowledgement given to Dr. Simon Allen for his medical research on the origin of chronic diseases. Moreover, his non-invasive treatment method, termed Thermobalancing therapy, and therapeutic Dr. Allen’s Devices are also approved at a national level.
On 8 November, 2014, The Academy of Medical Sciences of Armenia assessed and approved Thermobalancing therapy and the use of Dr. Allen's Devices for the treatment and prevention of chronic internal diseases. The approval was underpinned by clinical studies and recognition of Dr. Allen’s medical research on pathogenesis of chronic internal diseases.
Thermobalancing therapy is defined as a natural method of treatment and prevention of chronic internal diseases, which improves blood microcirculation in the damaged organs locally for a prolonged period of time; i.e. it treats the cause of a chronic disease.
Ariana Adjani, Co-Founder of Fine Treatment, comments: “I am delighted that the conclusions of this review include the endorsement of Thermobalancing therapy at the national level, and the approval of wider clinical studies on its efficacy.”
Overall, Fine Treatment has had a successful year. It has raised international awareness of the natural treatment with Thermobalancing therapy and Dr. Allen’s Devices, and the prospects of furthering this good cause are highly promising.
The efficacy of Thermobalancing therapy has been widely discussed at international medical conferences. It is backed by abundant empirical evidence and clinical research.
The results of clinical trials were presented at 2 international medical summits during the summer of 2014. Further urological, cardio and neurological research is going ahead, and more studies are planned to follow.
Fine Treatment welcomes co-operation with medical professionals and strives to inform people about all aspects of treatment with Thermobalancing therapy.
Patients’ feedback is encouraging. “Customer feedback has been highly positive and extremely valuable,” comments Ariana Adjani. “It is a pleasure to see that the treatment with Thermobalancing therapy and Dr. Allen’s Devices has made a profound impact on the lives of people worldwide.”
“Thermobalancing therapy and Dr. Allen’s Devices are safe, non-invasive, cause no side effects, and can be helpful to a wide range of patients,” says Ariana Adjani quoting the notes of medical experts. “Moreover, Dr. Allen’s Devices are designed for an easy everyday use.”
Informative videos show the simplicity of use of Dr. Allen’s Devices. Men with chronic prostatitis or benign prostatic hyperplasia (BPH) can see how to wear Dr. Allen’s Device for Prostate Care here: http://youtu.be/If6yogDKQkk. Lower back pain sufferers can achieve a notable pain relief and improved mobility by using Dr. Allen’s Device for Spine Care: http://youtu.be/HEgck2CAckg. Dr. Allen’s Device for the treatment of coronary heart disease is designed as a vest, http://youtu.be/fqGlgJAHYnM, and can be worn easily throughout the day and at night.
For details, visit Fine Treatment at http://finetreatment.com/.
About Dr. Simon Allen and Fine Treatment:
Dr. Simon Allen, MD, PhD, Academician, member of the ATA, is a highly experienced medical professional specializing in internal medicine. He has treated a wide range of chronic diseases, including patients after a heart attack, stroke, with kidneys problems, including kidney stones disease, prostate and spine conditions, as well as metabolic disorders.
Fine Treatment supports global customer outreach and ensures international availability of Dr. Allen’s Devices for the treatment of chronic prostatitis; BPH; coronary heart disease; for the natural support of brain function; for dissolving kidney stones; and for a powerful relief of upper and lower back pain, and sciatica.
Alex Day, Fine Treatment, http://www.finetreatment.com, +44 7958878300, [email protected]
Share this article